HOLSTEIN ROGER C 4
Research Summary
AI-generated summary
Progyny (PGNY) Director Roger Holstein Receives Awards
What Happened Roger C. Holstein, a director of Progyny, received equity awards on May 21, 2026. The filing shows: a stock option covering 4,003 shares with an exercise price of $12.49 (listed value ~$49,997) and restricted stock units (RSUs) totaling 36,081 shares (6,792 and 29,289 RSUs). These were grants/awards (code A), not open-market purchases or sales — they are compensation/retainer-related awards subject to vesting.
Key Details
- Transaction date: May 21, 2026; Filing date: May 26, 2026 (filing appears late; transactionTimeliness = 'L').
- Option: 4,003-share option at $12.49 per share (total shown $49,997). Footnote F2: option issued in lieu of an annual cash retainer ($49,978).
- RSUs: 6,792 and 29,289 RSUs granted (total 36,081 RSUs). Footnote F1: each RSU converts to one share upon vesting.
- Vesting: Footnotes F1–F3 indicate vesting occurs on the earlier of May 21, 2027 or the calendar day immediately before the issuer’s first annual meeting after the grant, subject to continued service.
- Shares owned after transaction: not disclosed in the filing.
- No exercise or sale occurred — these are grants/derivative awards, not liquidity events.
Context
- RSUs represent a contingent right to receive common stock upon vesting; they have no immediate trading value until vested and delivered.
- The option has an exercise price ($12.49) and will vest per the schedule above; it was granted as compensation rather than exercised for cash.
- Because the Form 4 was filed after the typical 2-business-day window, the late filing delays public disclosure of the grant and may be noted by investors and regulators.